1-1 of 1
Keywords: soluble epoxide hydrolase inhibitor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Inhibition of soluble epoxide hydrolase by cis -4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension

Jan Neckář, Libor Kopkan, Zuzana Husková, František Kolář, František Papoušek, Herbert J. Kramer, Sung Hee Hwang, Bruce D. Hammock, John D. Imig, Jiří Malý, Ivan Netuka, Bohuslav Ošťádal, Luděk Červenka
Journal: Clinical Science
Clin Sci (Lond) (2012) 122 (11): 513–527.
https://doi.org/10.1042/CS20110622
Published: 10 February 2012
... (email [email protected] ). 1 12 2011 16 12 2011 16 12 2011 © The Authors Journal compilation © 2012 Biochemical Society 2012 angiotensin II epoxyeicosatrienoic acid hypertension kidney myocardial ischaemia/reperfusion injury soluble epoxide hydrolase inhibitor...
View article titled, Inhibition of soluble epoxide hydrolase by cis -4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension
Open the PDF for Inhibition of soluble epoxide hydrolase by cis -4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension in another window
Includes: Supplementary data